Boston Scientific starts Cognis clinical trial bi13522245 Boston Corp. (NYSE:BSX) looking to get back on feet after a series of mis-steps for cardiac defibrillator operations. The Natick, Mass.-based medical device maker enrolled the first patient MultiSense clinical trial, aimed at evaluating the use of multiple sensors Cognis cardiac resynchronization therapy defibrillators. Boston said plans to []..

Boston Scientific Announces First Patient Enrollment MultiSENSE Clinical T bi13522245 NATICK, Mass., July 8 /PRNewswire-FirstCall/ -- Boston Corporation (NYSE: BSX) today announced enrollment of the first patient MultiSENSE clinical trial. The trial designed to evaluate multiple physiologic sensors the Company's COGNIS(TM) cardiac resynchronization therapy defibrillators (CRT-Ds). Boston plans to use the trial data to help develop a clinical ..

First patient enrolled Boston Scientific's MultiSENSE clinical trial bi13522245 Boston Corporation today announced enrollment of the first patient MultiSENSE clinical trial. The trial designed to evaluate multiple physiologic sensors the Company's COGNIS cardiac resynchronization therapy defibrillators. Boston plans to use the trial data to help develop a clinical alert that identifies the early onset of worsening heart failure

Boston Scientific to Webcast Conference Call Discussing Second Quarter Financ bi13522245 NATICK, Mass., July 7 /PRNewswire-FirstCall/ -- Boston Corporation (NYSE: BSX) webcast conference call discussing financial results for the second quarter ended June 30, 2010 on Wednesday, July 21, at 8:00 a.m. ET. The call be hosted by Ray Elliott, President and Chief Executive Officer, and Jeff Capello, Executive Vice President and Chief Financial Officer. The live ..

Amneal Appoints Dr. Shankar Hariharan as Chief Scientific Officer/EVP of Spec bi13522245 HAUPPAUGE, N.Y.----Amneal Pharmaceuticals pleased to announce that Dr. Shankar Hariharan has joined the company as Chief Officer/Executive Vice President of Specialty Pharmaceuticals

Acasti Pharma Inc. Welcomes Professor Jacques Genest to Its Scientific Adviso bi13522245 LAVAL, Quebec -- Neptune Technologies & Bioressources Inc. and Acasti Pharma Inc. are pleased to announce the expansion of Acasti's Advisory Board by welcoming Pr. Jacques Genest, MD, CM; FRCP; FACC; FAHA, to join Pr

Boston Scientific starts Cognis clinical trial bi13522245 Boston Corp. (NYSE:BSX) looking to get back on feet after a series of mis-steps for cardiac defibrillator operations. The Natick, Mass.-based medical device maker enrolled the first patient MultiSense clinical trial, aimed at evaluating the use of multiple sensors Cognis cardiac resynchronization therapy defibrillators. Boston said plans to []..

Boston Scientific Announces First Patient Enrollment MultiSENSE Clinical T bi13522245 NATICK, Mass., July 8 /PRNewswire-FirstCall/ -- Boston Corporation (NYSE: BSX) today announced enrollment of the first patient MultiSENSE clinical trial. The trial designed to evaluate multiple physiologic sensors the Company's COGNIS(TM) cardiac resynchronization therapy defibrillators (CRT-Ds). Boston plans to use the trial data to help develop a clinical ..

First patient enrolled Boston Scientific's MultiSENSE clinical trial bi13522245 Boston Corporation today announced enrollment of the first patient MultiSENSE clinical trial. The trial designed to evaluate multiple physiologic sensors the Company's COGNIS cardiac resynchronization therapy defibrillators. Boston plans to use the trial data to help develop a clinical alert that identifies the early onset of worsening heart failure

Boston Scientific to Webcast Conference Call Discussing Second Quarter Financ bi13522245 NATICK, Mass., July 7 /PRNewswire-FirstCall/ -- Boston Corporation (NYSE: BSX) webcast conference call discussing financial results for the second quarter ended June 30, 2010 on Wednesday, July 21, at 8:00 a.m. ET. The call be hosted by Ray Elliott, President and Chief Executive Officer, and Jeff Capello, Executive Vice President and Chief Financial Officer. The live ..

Amneal Appoints Dr. Shankar Hariharan as Chief Scientific Officer/EVP of Spec bi13522245 HAUPPAUGE, N.Y.----Amneal Pharmaceuticals pleased to announce that Dr. Shankar Hariharan has joined the company as Chief Officer/Executive Vice President of Specialty Pharmaceuticals

Acasti Pharma Inc. Welcomes Professor Jacques Genest to Its Scientific Adviso bi13522245 LAVAL, Quebec -- Neptune Technologies & Bioressources Inc. and Acasti Pharma Inc. are pleased to announce the expansion of Acasti's Advisory Board by welcoming Pr. Jacques Genest, MD, CM; FRCP; FACC; FAHA, to join Pr

Patriot Data Solutions Group Affirms Go To Market Strategy bi13522245 CARLSBAD, Calif., July 8 /PRNewswire-FirstCall/ -- Patriot Corporation (OTC Bulletin Board: PTSC) today reported initial success of the go-to-market strategy for wholly owned subsidiary, Patriot Data Solutions Group (PDSG). "With the assistance of strategic consultants at Attain, LLC, we have worked for several months to reposition PDSG through strategic planning and ..

Student Leadership Program - Home